Sign up to save your podcasts
Or
Share Ocular Therapeutix’ bold vision to redefine retinal disease treatment
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Ocular Therapeutix’ bold vision to redefine retinal disease treatment
Pravin Dugel, CEO of Ocular Therapeutix provides insights into existing treatments and future product candidates for retinal diseases, underlining the unique challenges, opportunities and innovations in this evolving landscape.
www.ocutx.com
Pravin U. Dugel, MD Biography
View all episodes
By RBC Capital Markets
5
1212 ratings
Pravin Dugel, CEO of Ocular Therapeutix provides insights into existing treatments and future product candidates for retinal diseases, underlining the unique challenges, opportunities and innovations in this evolving landscape.
www.ocutx.com
Pravin U. Dugel, MD Biography
More shows like Pathfinders in Biopharma
View all
The Bill Simmons Podcast
30,136 Listeners
RBC's Markets in Motion
40 Listeners
Industries in Motion
10 Listeners
Powering Sustainable Ideas
0 Listeners
The Rest Is Politics
3,289 Listeners
Macro Minutes
3 Listeners
Strategic Alternatives
18 Listeners
The Rest Is Politics: US
2,300 Listeners